| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 68 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 67 |
| 2 | TACROLIMUS OINTMENT 0.1% | 67 |
| 3 | PREDNISONE | 66 |
| 4 | MYCOPHENOLATE MOFETIL | 55 |
| 5 | METHYLPREDNISOLONE | 43 |
| 6 | CYCLOPHOSPHAMIDE | 29 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 29 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 29 |
| 9 | DEXAMETHASONE | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXRAZOXANE FOR INJECTION | 5 | 0.0053 |
| 1 | ANIDULAFUNGIN | 5 | 0.0031 |
| 2 | ATOVAQUONE | 21 | 0.0025 |
| 3 | IDECABTAGENE VICLEUCEL | 2 | 0.0016 |
| 4 | VALGANCICLOVIR | 27 | 0.0014 |
| 5 | PURIXAN | 1 | 0.0013 |
| 6 | PHYTONADIONE | 11 | 0.0013 |
| 7 | REMDESIVIR | 15 | 0.0011 |
| 8 | TREOSULFAN | 3 | 0.0011 |
| 9 | AMPHOTERICIN B | 13 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 120 |
| 1 | Alkylating Drug [EPC] | 29 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 27 |
| 3 | Azole Antifungal [EPC] | 25 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 22 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 22 |
| 6 | Antimalarial [EPC] | 21 |
| 7 | Antiprotozoal [EPC] | 21 |
| 8 | Polyene Antifungal [EPC] | 21 |
| 9 | Glycopeptide Antibacterial [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-1 Adrenergic Agonist [EPC] | 11 | 0.0025 |
| 1 | Antimalarial [EPC] | 21 | 0.0020 |
| 2 | Antiprotozoal [EPC] | 21 | 0.0020 |
| 3 | Vitamin K [EPC] | 11 | 0.0013 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 27 | 0.0012 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 15 | 0.0011 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 13 | 0.0010 |
| 7 | Echinocandin Antifungal [EPC] | 8 | 0.0010 |
| 8 | Oxazolidinone Antibacterial [EPC] | 16 | 0.0005 |
| 9 | Polyene Antifungal [EPC] | 21 | 0.0005 |